Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of three-drug combination aliskiren/ramipril/amlodipine versus two-drug combinations rami…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus [Phase 4]
Phase 4 trial comparing the fixed-dose combination aliskiren/hydrochlorothiazide to amlodipine in patients with Stage 2 systolic hypertensio…
-
EMA withdrawal · 2011-05-19EMA Withdrawn: Enviage (aliskiren) — Novartis Europharm Ltd.
The EMAWithdrawn notice states Enviage (aliskiren) has been withdrawn from the European market for hypertension.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure [Phase 3]
Phase 3 trial comparing valsartan to enalapril on sitting systolic blood pressure in children with hypertension; the study is completed with…
-
FDA approval · 2011-05-19FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc., reflecting an approve…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-05-19FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc. T…
-
FDA approval · 2011-05-19FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the Spironolactone and Hydrochlorothiazide combination submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension [Phase 3]
Phase 3 trial evaluating the use of a fixed-dose combination of aliskiren and amlodipine as initial therapy for hypertension. Results were p…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension [Phase 3]
Phase 3 trial update on combination therapy to prevent cardiovascular events in patients with systolic hypertension; study terminated with r…
-
CLINICAL_TRIALS research · 2011-05-17Clinical Trial Update: Sympathetic Activity and Renal Denervation
This is a clinical trial update focused on sympathetic activity and renal denervation in hypertension. The current trial status is unknown.
-
FDA approval · 2011-05-12FDA Approved: MICARDIS HCT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for MICARDIS HCT (telmisartan/hydrochlorothiazide) from Boehringer Ingelheim Pharmaceuticals, In…
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Evaluation of Target Organs Damage in Hypertensive Patients
AstraZeneca-sponsored trial evaluating target organ damage in patients with hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide. [Phase 3]
Phase 3 safety and tolerability study of the combination of aliskiren and valsartan in hypertension, followed by long-term safety and tolera…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension [Phase 3]
A Phase 3 trial comparing aliskiren added to losartan versus losartan alone evaluated regression of left ventricular hypertrophy in overweig…
-
FDA label_change · 2011-05-09FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) filed by Viatris Specialty LLC. This action updates the produc…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of the fixed-dose combination aliskiren/amlodipine/hydrochlorothiazide in moderate-to-sever…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age [Phase 1, Phase 2]
Phase 1/2 study in hypertensive children and adolescents evaluated the safety, tolerability, and pharmacokinetics of aliskiren; results were…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus
A completed trial assessing the effectiveness and tolerability of Tarka (trandolapril/verapamil) in hypertensive patients at high risk of de…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure [Phase 3]
A Phase 3 trial evaluating dose response of valsartan on sitting systolic blood pressure in children aged 6 months to 5 years with hypertens…
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension [NA]
Clinical trial update indicating a completed study evaluating quinapril 40 mg with alpha-lipoic acid versus placebo for diabetes mellitus an…
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With Hypertension [NA]
A completed clinical trial evaluating the blood pressure effects of a nebivolol and hydrochlorothiazide combination in African American adul…
-
CLINICAL_TRIALS research · 2011-05-05Clinical Trial Update: Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome [Phase 4]
Phase 4 clinical trial update examining changes in endothelial function and biomarkers in African Americans with metabolic syndrome, focusin…
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population
A completed non-interventional study evaluating the safety, effectiveness, and tolerability of quinapril (Acupil) in an Indian population, w…
-
FDA approval · 2011-05-03FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension [Phase 3]
This Phase 3 trial evaluated the efficacy and safety of aliskiren alone and in combination with amlodipine for essential hypertension. The s…